Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015

To analyse the variation of hepatitis C virus (HCV) prevalence and genotype distribution and their determinants in people living with human immunodeficiency virus (HIV) who entered care between 1997 and 2015. HIV-infected patients enrolled in ICONA who were tested for HCV antibodies (HCV-Ab) were in...

Full description

Saved in:
Bibliographic Details
Published in:Clinical microbiology and infection 2018-04, Vol.24 (4), p.422-427
Main Authors: Rossetti, B., Bai, F., Tavelli, A., Galli, M., Antinori, A., Castelli, F., Pellizzer, G., Cozzi-Lepri, A., Bonora, S., Monforte, A.d'Arminio, Puoti, M., De Luca, A.
Format: Article
Language:eng
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To analyse the variation of hepatitis C virus (HCV) prevalence and genotype distribution and their determinants in people living with human immunodeficiency virus (HIV) who entered care between 1997 and 2015. HIV-infected patients enrolled in ICONA who were tested for HCV antibodies (HCV-Ab) were included. Overall 3407 of 12 135 (28.1%) were HCV-Ab+; and 735 of 12 135 (6.1%) were HBsAg+. Among patients whose HCV genotype was known, the most represented were genotypes 1 and 3. The prevalence of HCV infection decreased from 49.2% (2565/5217) during 1997–2002 to 10.2% (556/5466) during 2009–2015. The frequency of genotype 1a increased from 29.0% (264/911) to 43.0% (129/300), whereas genotype 3 decreased from 38.5% (351/911) to 27.0% (81/300). Independent predictors of HCV-Ab+ status were being female (adjusted OR (AOR) 1.23, 95% CI 1.04–1.50, p = 0.01), risk category (versus injecting drug users: men who have sex with men AOR 0.01, 95% CI 0.01–0.01, p
ISSN:1198-743X
1469-0691